Company Information

BeiGene

Member Type

PCSC Corporate

Organization Type

Manufacturer

Description

BeiGene is a research based pharmaceutical company which carries out the discovery of innovative medicines, research programs and experimentation, with pharmaceutical products. BeiGene's medicines include tislelizumab, an immune checkpoint inhibitor and zanubrutinib, a Bruton's Tyrosine kinase inhibitor which became the first cancer drug developed in China to gain approval from the US Food and Drug Administration to treat mantle cell lymphoma in November 2019.

Contact Information

55 Challenger Rd Ste. 501

Ridgefield Park, NJ 07660

http://www.beigene.com

(781)801-1800

Staff

  • Keenan, Michael

    Director, Global Supply Chain Security, BeiGene

  • Smith, Scott

    Associate Director, Global Supply Chain Security, BeiGene

  • Thomas, Torry

    Director National Accounts Integrated Delivery Networks & HS, BeiGene
Start a New Company Search